This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Spain, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug MOTILIUM contains one active pharmaceutical ingredient (API):

1 Domperidone

Domperidone is a dopamine antagonist with anti-emetic properties, Domperidone does not readily cross the blood-brain barrier. In domperidone users, especially in adults, extrapyramidal side effects are very rare, but domperidone promotes the release of prolactin from the pituitary.

Read about Domperidone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MOTILIUM Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A03FA03 Domperidone A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03F Propulsives → A03FA Propulsives
Discover more medicines within A03FA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1347X
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 514502401135317, 514502403111318, 514502404118316, 514502405130311, 514502406137318, 514502407117310, 514512020024803
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 01693376, 01693407, 02084550, 02334202, 02334219, 02739979, 03050843, 03050866
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 27.253-09-06
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 55410, 55411
Country: FR Base de données publique des médicaments Identifier(s): 63679194, 69742865
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 15659, 15662
Country: HK Department of Health Drug Office Identifier(s): 48305
Country: IE Health Products Regulatory Authority Identifier(s): 74284
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4332
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1011620, 1011621, 1034132, 1068246, 1080373, 1087568, 1088479, 1090112
Country: MT Medicines Authority Identifier(s): AA521/02004, AA908/04804, MA1471/00501, PI908/04801A
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 0041M79, 0042M79
Country: NG Registered Drug Product Database Identifier(s): 04-1293
Country: NL Z-Index G-Standaard Identifier(s): 12134171
Country: NL Z-Index G-Standaard, PRK Identifier(s): 6289
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 3558
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W12227001, W12227002
Country: SG Health Sciences Authority Identifier(s): 02500P, 02891P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699593095382, 8699593701054
Country: ZA Health Products Regulatory Authority Identifier(s): K/5.7.2/261, V/5.7.2/19

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.